Abstract:Objective To evaluate the safety and efficacy of transcatheter closure of post-surgery residual ventricular septal defect( VSD)and its mid-to long-term follow-up results. Methods The clinical data of patients with post-surgery residual VSD who underwent an attempt of percutaneous device closure from September 2002 to December 2013 in Childrenˊs Hospital of Fudan University were summarized. Results 21 patients( 11 males and 10 females ) with post-surgery residual VSD underwent an attempt of percutaneous device closure in our center. The mean age was 8. 8 years(2. 7-21 years)and the mean weight was 26. 3 kg(10. 5-53. 5 kg). Among these 21 patients,their previous surgery procedures were VSD repair in 13 cases,repair of tetralogy of Fallot( TOF)in 5 cases,repair of double outlet right ventricle( DORV)in 2 cases,and repair of complete transposition of great arteries( TGA)with VSD in 1 case. In addition,1 patient of post-TOF repair was associated with frequently premature ventricular contraction and ventricular tachycardia,2 patients of post VSD repair were associated with recoarctation of the aorta. The duration between previous surgery and transcathter device closure was 11-80 months. The mean diameter of VSDs in right ventricle( RV) side was 3. 73 mm(1. 6-6. 3 mm)by angiogram. There were multiple shunts in RV side in 4 patients,and one patient was left ventricle to right atrium shunt. The Qp/Qs ratio was 1. 53 ± 0. 23,and there was no pulmonary hypertension more than moderate. Amplatzer devices were successfully deployed in all cases except for 1 failure case due to a repeat complete block during the arterial-venous loop establishing,and 2 devices were used in 1 patient. The median device size was 6. 5 mm(4 -12 mm). A radio-frequency ablation and 2 balloon dilatations were successfully finished for the associated defects in the same procedure. There was no procedure-related adverse events. Mild residual shunt was showed by angiogram and transthoracic echocardiography( TTE ) immediate after closure in 3 patients. Three patients with moderate to severe tricuspid regurgitation before device closure improved significantly after closure. All patients were doing well clinically in a mean 22. 2 months(1 - 79 months)follow up. Minor arrhythmia was observed in 2 patients in the first year follow-up ECG including incomplete right bundle branch and first-degree atrioventricular block,and remained the same in another 6 months to 1 year follow-up. All 3 residual shunts disappeared in the follow-up echocardiography except for a 3. 4 mm residual shunt still existed in 1 patient with normal heart size and function. No new onset tricuspid or aortic regurgitation was showed. There was no device malposition or embolization,or thrombosis formation. Conclusion Transcatheter closure of post-surgery residual ventricular septal defect is safe,effective and less trauma. The mid-to long-term follow-up results of these cases are promising.

Appraisal of efficacy and safety of ventricular septal defects device occlusion

Minimally Invasive Perventricular Device Closure of Perimembranous Ventricular Septal Defect Without Cardiopulmonary Bypass: Multicenter Experience and Mid-Term Follow-Up

Perimembranous Ventricular Septal Defect Performed Super Minimally Invasive Trans Intercostal Device Closure under the Guidance of Transesophageal Echocardiography in Children

Transcatheter Closure of Secundum Atrial Septal Defect with Amplatzer Occluder Device

Minimally Invasive Experiences on Perventricular Device Closure of Ventricular Septal Defects in Children

Transcatheter Closure of perimembranous ventricular septal defects with the Amplatzer asymmetris ventricular septal defect occluder:immediate results and long-term follow-up

Clinical Application of Amplatzer Occluder Device to Treat Perimembrane Ventricular Septal Defect: a Report of 6 Cases for Transcatheter Closure of VSD

Transthoracic Echocardiographic Value in Transcatheter Closure of Perimembranous Ventricular Septal Defect Using Amplatzer Occluder

Transcatheter closure of 34 cases with perimembranous ventricular septal defect

The efficacy and its mid-to long-term follow-up of transcathter closure of post-surgery residual ventricular septal defect of congenital heart disease

Clinical Application of Amplatzer Occluder Device to Treat Perimembrane Ventricular Septal Defect:A Report of 19 Cases for Transcatheter Closure of PMVSD

[Transesophageal Echocardiography-Guided Hybrid Therapy for Ventricular Septal Defects in Children].

[Effects of Transcatheter Closure of Perimembranous Ventricular Septal Defects: Intermediate and Long-Term Follow-Up of 68 Cases].

Transcatheter closure of ventricular septal defects using the new ventricular septal defects occluder

Transcatheter Closure Of Perimembranous Ventricular Septal Defect Using A Modified Double-Disk Occluder

Transcatheter Closure on Perimembranous Ventricular Septal Defect in Infants

Transcatheter closure of multi-hole perimembranous VSD with aneurysm: 3-year follow-up study

Transcatheter Device Closure of Perimembranous Ventricular Septal Defects: Mid-Term Outcomes.

Clinical effects of transcatheter occlusion of congenital ventricular septal defects

Outcome of Transcatheter Closure of Perimembranous Ventricular Septal Defect with Modified Double-Disk Occluder Device

Transcatheter closure of perimembranous ventricular septal defects in children following transthoracic echocardiography]